Literature DB >> 20339195

Impact of electrocardiographic left ventricular hypertrophy on the occurrence of cardiovascular events in elderly hypertensive patients. - The Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS) -.

Satoshi Jissho1, Kenei Shimada, Haruyuki Taguchi, Ken Yoshida, Shota Fukuda, Hidemasa Tanaka, Junichi Yoshikawa, Minoru Yoshiyama, Masao Ishii, Yoshio Goto.   

Abstract

BACKGROUND: Electrocardiographic (ECG) left ventricular hypertrophy (LVH) is a risk factor for cardiovascular events and the incidence of LVH increases with age. However, few studies have assessed risks associated with LVH in elderly hypertensive patients. METHODS AND
RESULTS: The Japanese Trial to Assess Optimal Systolic Blood Pressure in Elderly Hypertensive Patients (JATOS) was conducted to determine optimal blood pressure in elderly patients. At study entry, the sum of the S-wave in lead V(1) and the R-wave in lead V(5) (SV1+ RV5) could be determined in 3,230 patients, among whom 164 (5.1%) had cardiovascular events. On univariate analysis, the hazard ratio for cardiovascular events was 1.51 for each 10 mm (=1 mV) (95% confidence interval (CI): 1.34-1.69, P<0.0001) when SV1+ RV5 was considered a continuous variable, and 2.17 (95%CI: 1.54-3.05, P<0.0001) and 2.83 (95%CI: 1.91-4.19, P<0.0001) when SV1+ RV5 was classified into 2 groups at threshold values of either 35 mm or 40 mm, respectively. Multivariate Cox analysis showed that gender, age, current smoking, diabetes mellitus, history of renal disease, history of stroke, and SV1+ RV5 were significantly related to the occurrence of cardiovascular events. Kaplan - Meier curves showed that increasing SV1+ RV5 values were associated with higher incidences of cardiovascular events.
CONCLUSIONS: ECG LVH is strongly related to cardiovascular events in elderly hypertensive patients.

Entities:  

Mesh:

Year:  2010        PMID: 20339195     DOI: 10.1253/circj.cj-09-0722

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  6 in total

1.  Diagnostic performance of electrocardiographic criteria for left ventricular hypertrophy among various body mass index groups compared to diagnosis by cardiac magnetic resonance imaging.

Authors:  Veerawat Nomsawadi; Rungroj Krittayaphong
Journal:  Ann Noninvasive Electrocardiol       Date:  2019-02-05       Impact factor: 1.468

Review 2.  Update on pathophysiology and treatment of hypertension in the elderly.

Authors:  Debbie L Cohen; Raymond R Townsend
Journal:  Curr Hypertens Rep       Date:  2011-10       Impact factor: 5.369

3.  Addition of N-terminal pro-B-type natriuretic peptide levels to electrocardiography criteria for detection of left ventricular hypertrophy: the ARIRANG study.

Authors:  Min-Soo Ahn; Byung-Su Yoo; Ji Hyun Lee; Jun-Won Lee; Young Jin Youn; Sung Gyun Ahn; Jang-Young Kim; Seung-Hwan Lee; Junghan Yoon; Jong-Ku Park; Song Vogue Ahn; Eunhee Choi
Journal:  J Korean Med Sci       Date:  2015-03-19       Impact factor: 2.153

4.  Electrocardiographic left ventricular hypertrophy and mortality in an oldest-old hypertensive Chinese population.

Authors:  Rui Chen; Kunhao Bai; Fanghong Lu; Yingxin Zhao; Yujing Pan; Fang Wang; Luxia Zhang
Journal:  Clin Interv Aging       Date:  2019-09-17       Impact factor: 4.458

5.  Electrocardiographic criteria which have the best prognostic significance in hypertensive patients with echocardiographic hypertrophy of left ventricle: 15-year prospective study.

Authors:  Dragan B Djordjevic; Ivan S Tasic; Svetlana T Kostic; Bojana N Stamenkovic; Milan B Lovic; Nikola D Djordjevic; Goran P Koracevic; Dragan B Lovic
Journal:  Clin Cardiol       Date:  2020-06-03       Impact factor: 2.882

6.  Prognostic value of left ventricular hypertrophy in hypertensive patients: A meta-analysis of electrocardiographic studies.

Authors:  Hongsheng Zhang; Lingai Hu; Xiqing Wei
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-01-19       Impact factor: 3.738

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.